[1]
Kareem Ali Maher, Reda Biomy Bastawesy, Mahmoud Mohammed AbdouYossef, Mariam Salah Zaghlol, and Wael Anwer Haseeb, “Cardiovascular Risk Assessment after Sofosbuvir and Daclatasvir Regimen for Chronic Hepatitis C Virus Infection”, J Pak Med Assoc, vol. 73, no. 4, pp. S136-S141, May 2023.